বুধবার, ২৪ এপ্রিল, ২০১৩

A potential biomarker for pregnancy-associated heart disease?

A potential biomarker for pregnancy-associated heart disease? [ Back to EurekAlert! ] Public release date: 24-Apr-2013
[ | E-mail | Share Share ]

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation

Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history of heart disease and the causes are not well understood. In this issue of the Journal of Clinical Investigation, Ingrid Struman and colleagues at the University of Liege in Liege, Belgium, identified a molecule, miR-146a, that can serve as a biomarker for peripartum cardiomyopathy. Struman and colleagues found that expression of miR-146a was induced by the nursing hormone prolactin. MiR-146a expression promoted vascular damage and was increased in a mouse model of PPCM. Conversely, loss of miR-146a in mice prevented PPCM. Importantly, miR-146a expression was elevated in the serum of pregnant women who developed PPCM, suggesting that serum miR-146a levels could predict which patients are at risk for the disease. In a companion commentary, Richard Kitsis of Albert Einstein College of Medicine in New York, discusses the potential implications of this work for the identification and treatment of PPCM.

###

TITLE: MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

AUTHOR CONTACT:
Ingrid Struman
University of Liege, Liege, BEL
Phone: +3243663566; E-mail: i.struman@ulg.ac.be

View this article at: http://www.jci.org/articles/view/64365?key=54a58644d5c203c3b462

ACCOMPANYING COMMENTARY

TITLE: A microRNA links prolactin to peripartum cardiomyopathy

AUTHOR CONTACT:
Richard N Kitsis
Albert Einstein College of Medicine, Bronx, NY, USA
Phone: (718) 430-2609; Fax: (718) 430-8989; E-mail: richard.kitsis@einstein.yu.edu

View this article at: http://www.jci.org/articles/view/69286?key=ea00e37108ce3ec09bd1


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


A potential biomarker for pregnancy-associated heart disease? [ Back to EurekAlert! ] Public release date: 24-Apr-2013
[ | E-mail | Share Share ]

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation

Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history of heart disease and the causes are not well understood. In this issue of the Journal of Clinical Investigation, Ingrid Struman and colleagues at the University of Liege in Liege, Belgium, identified a molecule, miR-146a, that can serve as a biomarker for peripartum cardiomyopathy. Struman and colleagues found that expression of miR-146a was induced by the nursing hormone prolactin. MiR-146a expression promoted vascular damage and was increased in a mouse model of PPCM. Conversely, loss of miR-146a in mice prevented PPCM. Importantly, miR-146a expression was elevated in the serum of pregnant women who developed PPCM, suggesting that serum miR-146a levels could predict which patients are at risk for the disease. In a companion commentary, Richard Kitsis of Albert Einstein College of Medicine in New York, discusses the potential implications of this work for the identification and treatment of PPCM.

###

TITLE: MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

AUTHOR CONTACT:
Ingrid Struman
University of Liege, Liege, BEL
Phone: +3243663566; E-mail: i.struman@ulg.ac.be

View this article at: http://www.jci.org/articles/view/64365?key=54a58644d5c203c3b462

ACCOMPANYING COMMENTARY

TITLE: A microRNA links prolactin to peripartum cardiomyopathy

AUTHOR CONTACT:
Richard N Kitsis
Albert Einstein College of Medicine, Bronx, NY, USA
Phone: (718) 430-2609; Fax: (718) 430-8989; E-mail: richard.kitsis@einstein.yu.edu

View this article at: http://www.jci.org/articles/view/69286?key=ea00e37108ce3ec09bd1


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-04/joci-apb041713.php

raspberry ketone ron burgundy millennial media nit championship transcendentalism bells palsy channel 5 news

কোন মন্তব্য নেই:

একটি মন্তব্য পোস্ট করুন